+987.9%
MRNA vs RGEN
+19.5%
+968.4%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | RGEN | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | 0.0% | +13.1% | +13.1% |
| 7D | +20.6% | -3.5% | +24.2% | +24.6% |
| 30D | +27.1% | -6.0% | +33.1% | +35.0% |
| 3M | +353.4% | +19.0% | +334.4% | +305.0% |
| 6M | +446.3% | +50.7% | +395.5% | +324.1% |
| YTD | +776.2% | +8.8% | +767.4% | +818.1% |
| 1Y | +987.9% | +21.3% | +966.6% | +912.6% |
| All | +987.9% | +19.5% | +968.4% | +912.6% |
Cumulative growth
Daily Returns
Daily percentage return beside RGEN.
Daily Out/Under-Performance
Portfolio return minus RGEN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RGEN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded RGEN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling